Allworth Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89M Sell
49,775
-36,596
-42% -$2.95M 0.02% 394
2026
Q1
$7.48M Sell
86,371
-240
-0.3% -$23K 0.03% 296
2025
Q4
$8.32M Buy
86,611
+32,491
+60% +$3.16M 0.03% 270
2025
Q3
$5.15M Buy
54,120
+8,261
+18% +$759K 0.02% 312
2025
Q2
$4M Buy
45,859
+8,048
+21% +$683K 0.02% 344
2025
Q1
$3.19M Sell
37,811
-2,597
-6% -$232K 0.02% 326
2024
Q4
$3.55M Buy
40,408
+12,055
+43% +$1.04M 0.02% 305
2024
Q3
$2.55M Buy
28,353
+2,859
+11% +$241K 0.02% 297
2024
Q2
$2.03M Sell
25,494
-3,948
-13% -$324K 0.01% 330
2024
Q1
$2.57M Buy
29,442
+6,490
+28% +$554K 0.02% 276
2023
Q4
$1.89M Buy
22,952
+3,933
+21% +$300K 0.01% 314
2023
Q3
$1.49M Sell
19,019
-8,232
-30% -$689K 0.01% 320
2023
Q2
$2.4M Buy
27,251
+3,544
+15% +$305K 0.02% 254
2023
Q1
$1.91M Buy
23,707
+1,486
+7% +$121K 0.02% 261
2022
Q4
$1.73M Buy
22,221
+1,109
+5% +$89.9K 0.02% 261
2022
Q3
$1.71M Sell
21,112
-2,273
-10% -$204K 0.02% 243
2022
Q2
$2.1M Buy
23,385
+1,363
+6% +$138K 0.03% 211
2022
Q1
$2.44M Buy
22,022
+2,160
+11% +$228K 0.03% 200
2021
Q4
$2.06M Sell
19,862
-369
-2% -$42.7K 0.03% 200
2021
Q3
$2.54M Sell
20,231
-62
-0.3% -$8.03K 0.04% 147
2021
Q2
$2.52M Buy
20,293
+349
+2% +$43.8K 0.05% 117
2021
Q1
$2.36M Buy
19,944
+10,295
+107% +$1.21M 0.05% 105
2020
Q4
$1.13M Sell
9,649
-505
-5% -$55.6K 0.03% 111
2020
Q3
$1.05M Buy
10,154
+727
+8% +$73K 0.03% 93
2020
Q2
$864K Sell
9,427
-11,732
-55% -$1.12M 0.03% 106
2020
Q1
$1.91M Buy
21,159
+13,712
+184% +$1.46M 0.06% 72
2019
Q4
$845K Hold
7,447
0.03% 80
2019
Q3
$809K Hold
7,447
0.03% 73
2019
Q2
$725K Sell
7,447
-83
-1% -$7.58K 0.03% 78
2019
Q1
$686K Buy
7,530
+209
+3% +$18.7K 0.03% 78
2018
Q4
$666K Buy
7,321
+125
+2% +$11.7K 0.03% 76
2018
Q3
$708K Sell
7,196
-14
-0.2% -$1.29K 0.03% 77
2018
Q2
$617K Sell
7,210
-36
-0.5% -$3.01K 0.03% 81
2018
Q1
$581K Sell
7,246
-50
-0.7% -$4.12K 0.04% 58
2017
Q4
$589K Buy
7,296
+100
+1% +$8.01K 0.05% 53
2017
Q3
$560K Sell
7,196
-85
-1% -$7.06K 0.05% 55
2017
Q2
$646K Buy
7,281
+35
+0.5% +$2.95K 0.06% 49
2017
Q1
$584K Hold
7,246
0.06% 49
2016
Q4
$516K Sell
7,246
-189
-3% -$14.8K 0.05% 53
2016
Q3
$642K Buy
7,435
+156
+2% +$13.6K 0.07% 46
2016
Q2
$632K Buy
7,279
+84
+1% +$6.79K 0.07% 50
2016
Q1
$540K Hold
7,195
0.07% 55
2015
Q4
$553K Hold
7,195
0.1% 54
2015
Q3
$482K Sell
7,195
-1
-0% -$74 0.17% 56
2015
Q2
$533K Hold
7,196
0.19% 52
2015
Q1
$561K Buy
7,196
+76
+1% +$5.76K 0.21% 47
2014
Q4
$514K Buy
7,120
+33
+0.5% +$2.29K 0.19% 45
2014
Q3
$439K Sell
7,087
-1,665
-19% -$106K 0.17% 49
2014
Q2
$558K Buy
8,752
+33
+0.4% +$2K 0.25% 30
2014
Q1
$537K Buy
8,719
+32
+0.4% +$1.86K 0.24% 26
2013
Q4
$499K Buy
8,687
+504
+6% +$28.6K 0.25% 29
2013
Q3
$436K Buy
8,183
+1,262
+18% +$67.9K 0.23% 37
2013
Q2
$356K Buy
+6,921
New +$342K 0.2% 38

Other funds holding MDT

Allworth Financial's MDT Position: Q2 2026 in Review

Allworth Financial reduced its Medtronic (MDT) stake by 42% in Q2 2026, selling an estimated $2.95M and leaving 49,775 shares worth $3.89M. The position accounts for 0.02% of the portfolio, ranked #394.

Allworth Financial first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.32M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Allworth Financial held 49,775 shares of Medtronic worth $3.89M as of Q2 2026.
  • Allworth Financial sold 36,596 Medtronic shares in Q2 2026, an estimated $2.95M.
  • Medtronic made up 0.02% of Allworth Financial's portfolio in Q2 2026, its #394 holding.
  • Allworth Financial first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Allworth Financial's Medtronic position peaked at $8.32M in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.